Syquant Capital’s IVERIC bio ISEE Stock Holding History
Bought
Maintained
Sold
Syquant Capital's ISEE Position: Q3 2023 in Review
Syquant Capital sold out of IVERIC bio (ISEE) in Q3 2023, closing a stake of 406,686 shares — an estimated $16M sold.
Syquant Capital first reported a position in ISEE in Q2 2023 and held it in 1 quarter. The position peaked at $16M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- Syquant Capital reported no remaining IVERIC bio position as of Q3 2023 after selling out during the quarter.
- Syquant Capital sold 406,686 IVERIC bio shares in Q3 2023, an estimated $16M.
- Syquant Capital first reported a position in IVERIC bio in Q2 2023 and held it in 1 quarter.
- Syquant Capital's IVERIC bio position peaked at $16M in Q2 2023.
- 0 funds tracked by Wall St. Rank held IVERIC bio as of Q3 2023.
Based on Syquant Capital's 13F filing for Q3 2023, filed 12 Oct 2023.